Health Catalyst Inc reports results for the quarter ended in March - Earnings Summary
Health Catalyst Inc HCAT reported quarterly adjusted earnings of 5 cents per share for the quarter ended in March, identical to the same quarter last year. The mean expectation of fifteen analysts for the quarter was for earnings of 3 cents per share. Wall Street expected results to range from -6 cents to 6 cents per share.
Revenue rose 1.2% to $74.72 million from a year ago; analysts expected $74.80 million.
Health Catalyst Inc's reported EPS for the quarter was a loss of 35 cents.
The company reported a quarterly loss of $20.59 million.
Health Catalyst Inc shares had fallen by 11.7% this quarter and lost 28.2% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 6% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 12 "strong buy" or "buy," 5 "hold" and no "sell" or "strong sell."
The average consensus recommendation for the software peer group is also "buy"
Wall Street's median 12-month price target for Health Catalyst Inc is $11.50
This summary was machine generated from LSEG data May 9 at 10:39 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Mar. 31 2024 | 0.03 | 0.05 | Beat |
Dec. 31 2023 | 0.00 | 0.02 | Beat |
Sep. 30 2023 | -0.02 | 0.03 | Beat |
Jun. 30 2023 | 0.00 | 0.05 | Beat |